相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients with Advanced/Metastatic Solid Tumors or Lymphomas
Funda Meric-Bernstam et al.
CLINICAL CANCER RESEARCH (2022)
TGFβ biology in cancer progression and immunotherapy
Rik Derynck et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Amplifying STING activation by cyclic dinucleotide-manganese particles for local and systemic cancer metalloimmunotherapy
Xiaoqi Sun et al.
NATURE NANOTECHNOLOGY (2021)
CXCL9-expressing tumor-associated macrophages: new players in the fight against cancer
Paola Marie Marcovecchio et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Prolonged activation of innate immune pathways by a polyvalent STING agonist
Suxin Li et al.
NATURE BIOMEDICAL ENGINEERING (2021)
Intratumoral and s.c. injection of inactivated hemagglutinating virus of Japan envelope (GEN0101) in metastatic castration-resistant prostate cancer
Kazutoshi Fujita et al.
CANCER SCIENCE (2020)
The Cytosolic DNA-Sensing cGAS-STING Pathway in Cancer
John Kwon et al.
CANCER DISCOVERY (2020)
CCL2/CCR2 signaling in cancer pathogenesis
Qiongyu Hao et al.
CELL COMMUNICATION AND SIGNALING (2020)
Clinical landscape of oncolytic virus research in 2020
Nicholas Macedo et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Overcoming resistance to STING agonist therapy to incite durable protective antitumor immunity
Henrique Lemos et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Enhancing cancer immunotherapy with nanomedicine
Darrell J. Irvine et al.
NATURE REVIEWS IMMUNOLOGY (2020)
A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization (vol 175, pg 313, 2018)
Miguel F. Sanmamed et al.
CELL (2019)
Immunological basis for enhanced immunity of nanoparticle vaccines
Hannah G. Kelly et al.
EXPERT REVIEW OF VACCINES (2019)
Cancer Vaccines: Steering T Cells Down the Right Path to Eradicate Tumors
Patrick A. Ott et al.
CANCER DISCOVERY (2019)
Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy
Melvyn T. Chow et al.
IMMUNITY (2019)
Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors
Denarda Dangaj et al.
CANCER CELL (2019)
CXCR3-CXCL9: It's All in the Tumor
Etienne Humblin et al.
IMMUNITY (2019)
MHC-II neoantigens shape tumour immunity and response to immunotherapy
Elise Alspach et al.
NATURE (2019)
CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review
Bagher Farhood et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Actively personalized vaccination trial for newly diagnosed glioblastoma
Norbert Hilf et al.
NATURE (2019)
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
Derin B. Keskin et al.
NATURE (2019)
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
Jonathan J. Havel et al.
NATURE REVIEWS CANCER (2019)
Designer vaccine nanodiscs for personalized cancer immunotherapy
Rui Kuai et al.
NATURE MATERIALS (2017)
Synthetic nanovaccines for immunotherapy
Min Luo et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Ugur Sahin et al.
NATURE (2017)
Elements of cancer immunity and the cancer-immune set point
Daniel S. Chen et al.
NATURE (2017)
An immunogenic personal neoantigen vaccine for patients with melanoma
Patrick A. Ott et al.
NATURE (2017)
A STING-activating nanovaccine for cancer immunotherapy
Min Luo et al.
NATURE NANOTECHNOLOGY (2017)
cGAS is essential for the antitumor effect of immune checkpoint blockade
Hua Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
NK cell-based immunotherapy for cancer
Fang Fang et al.
SEMINARS IN IMMUNOLOGY (2017)
The present status and future prospects of peptide-based cancer vaccines
Masatoshi Hirayama et al.
INTERNATIONAL IMMUNOLOGY (2016)
Beyond antigens and adjuvants: formulating future vaccines
Tyson J. Moyer et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Nanoparticle-Based Modulation of the Immune System
Ronnie H. Fang et al.
ANNUAL REVIEW OF CHEMICAL AND BIOMOLECULAR ENGINEERING, VOL 7 (2016)
Oncogenic CXCL10 signalling drives metastasis development and poor clinical outcome
S. C. Wightman et al.
BRITISH JOURNAL OF CANCER (2015)
Synthetic Nanoparticles for Vaccines and Immunotherapy
Darrell J. Irvine et al.
CHEMICAL REVIEWS (2015)
In situ vaccination: Cancer immunotherapy both personalized and off-the-shelf
Linda Hammerich et al.
MOLECULAR ONCOLOGY (2015)
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
R. J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Immunomodulatory spherical nucleic acids
Aleksandar F. Radovic-Moreno et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity
Leticia Corrales et al.
CELL REPORTS (2015)
Intratumoral Immunization: A New Paradigm for Cancer Therapy
Aurelien Marabelle et al.
CLINICAL CANCER RESEARCH (2014)
Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion
Yared Hailemichael et al.
NATURE MEDICINE (2013)
The Ratios of CD8+ T Cells to CD4+ CD25+ FOXP3+ and FOXP3- T Cells Correlate with Poor Clinical Outcome in Human Serous Ovarian Cancer
Claudia C. Preston et al.
PLOS ONE (2013)
Multicolored pH-Tunable and Activatable Fluorescence Nanoplatform Responsive to Physiologic pH Stimuli
Kejin Zhou et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma
Douglas J. Schwartzentruber et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
Martin F. Bachmann et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Immunotherapy of established (pre) malignant disease by synthetic long peptide vaccines
Cornelis J. M. Melief et al.
NATURE REVIEWS CANCER (2008)
Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma
SA Rosenberg et al.
JOURNAL OF IMMUNOLOGY (2005)
Intratumoral vaccination and diversified subcutaneous/intratumoral vaccination with recombinant poxviruses encoding a tumor antigen and multiple costimulatory molecules
C Kudo-Saito et al.
CLINICAL CANCER RESEARCH (2004)
Cancer immunotherapy: moving beyond current vaccines
SA Rosenberg et al.
NATURE MEDICINE (2004)
分享论文
